Resources for Collectors

This page includes resources and information for the blood community regarding COVID-19 convalescent plasma, or CCP. AABB will be regularly updating this page with content. If you have resources you wish to share or see please contact AABB.

Collection of CCP can be implemented immediately by AABB-accredited blood collectors. Collection, labeling and distribution of CCP should follow the recommendations in FDA’s May 2020 Guidance document. An FDA approved IND is required for labeling of CCP and for transfusion as an investigational treatment:

Investigational COVID-19 Convalescent Plasma; Guidance for Industry (Updated May 1, 2020)

AABB COVID-19 Convalescent Plasma Town Hall On-Demand eCast Series

(complimentary to AABB members through the support of Cerus Corporation)


This on-demand eCast series discusses the vein-to-vein considerations of collection and administration of COVID-19 convalescent plasma (CCP). It is presented in two segments: Donor Recruitment Considerations and Hospital Considerations.

Learn More